Home Use Intermittent Catheter Devices Market
Description
Home Use Intermittent Catheter Devices Market Summary
The global home use intermittent catheter devices market size was estimated at USD 1.74 billion in 2025 and is projected to reach USD 2.72 billion by 2033, growing at a CAGR of 5.8% from 2026 to 2033. The market is primarily driven by the rising prevalence of chronic urinary disorders and the growing elderly population requiring long-term bladder management.
A strong shift toward home-based self-care, supported by healthcare cost-containment efforts, is accelerating the adoption of self-care outside clinical settings. Technological advancements, including hydrophilic coatings, compact designs, and closed-system catheters, have enhanced safety, comfort, and ease of use for patients. In addition, increased awareness of lower infection risk compared to indwelling catheters continues to support market growth.
The rising prevalence of urological and neurological disorders such as spinal cord injuries, multiple sclerosis, urinary retention, and neurogenic bladder has significantly increased the need for long-term bladder management solutions. As many of these conditions require regular and ongoing catheterization, patients are opting for home-use intermittent catheters, which enable safe self-management, independence, and reduced reliance on clinical settings.
The rising prevalence of spinal cord injury (SCI) is driving growth in the home-use intermittent catheter device market, as many SCI patients require lifelong bladder management due to a neurogenic bladder. Increased emphasis on intermittent self-catheterization for home care, along with improved survival rates and a shift from hospital to home settings, is enhancing demand for easy-to-use intermittent catheters. For instance, according to the National Spinal Cord Injury Statistical Center, in 2024, approximately 308,620 individuals are currently living with traumatic spinal cord injury (tSCI) in the United States, with estimates ranging from 259,374 to 393,913 persons.
Home Use Intermittent Catheter Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global home use intermittent catheter devices market report based on product, user category, application, tip, distribution channel, and region:
The global home use intermittent catheter devices market size was estimated at USD 1.74 billion in 2025 and is projected to reach USD 2.72 billion by 2033, growing at a CAGR of 5.8% from 2026 to 2033. The market is primarily driven by the rising prevalence of chronic urinary disorders and the growing elderly population requiring long-term bladder management.
A strong shift toward home-based self-care, supported by healthcare cost-containment efforts, is accelerating the adoption of self-care outside clinical settings. Technological advancements, including hydrophilic coatings, compact designs, and closed-system catheters, have enhanced safety, comfort, and ease of use for patients. In addition, increased awareness of lower infection risk compared to indwelling catheters continues to support market growth.
The rising prevalence of urological and neurological disorders such as spinal cord injuries, multiple sclerosis, urinary retention, and neurogenic bladder has significantly increased the need for long-term bladder management solutions. As many of these conditions require regular and ongoing catheterization, patients are opting for home-use intermittent catheters, which enable safe self-management, independence, and reduced reliance on clinical settings.
The rising prevalence of spinal cord injury (SCI) is driving growth in the home-use intermittent catheter device market, as many SCI patients require lifelong bladder management due to a neurogenic bladder. Increased emphasis on intermittent self-catheterization for home care, along with improved survival rates and a shift from hospital to home settings, is enhancing demand for easy-to-use intermittent catheters. For instance, according to the National Spinal Cord Injury Statistical Center, in 2024, approximately 308,620 individuals are currently living with traumatic spinal cord injury (tSCI) in the United States, with estimates ranging from 259,374 to 393,913 persons.
Home Use Intermittent Catheter Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global home use intermittent catheter devices market report based on product, user category, application, tip, distribution channel, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Coated Catheters (Hydrophilic)
- Uncoated Catheters
- User Category Outlook (Revenue, USD Million, 2021 - 2033)
- Male
- Female
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Urinary Incontinence (UI)
- Neurogenic Bladder
- Urinary Retention
- Post-Surgical Care
- Tip Outlook (Revenue, USD Million, 2021 - 2033)
- Straight
- Coudé
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- DME / Home Care Providers
- Online Pharmacies / E-Commerce
- Retail Pharmacies
- Hospital Stores / Outpatient Clinics
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
120 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Component outlook
- 2.2.2. Application outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Telesurgery Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Telesurgery: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.2. PESTLE Analysis
- 3.4. Regulatory Framework
- 3.5. Technology landscape
- Chapter 4. Telesurgery Market Segment Analysis, By Component, 2021-2033 (USD Million)
- 4.1. Definition and Scope
- 4.2. Component Market Share Analysis, 2025 & 2033
- 4.3. Segment Dashboard
- 4.4. Global Telesurgery Market, by Component, 2021 to 2033
- 4.5. System
- 4.5.1. System market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6. Instrument & accessories
- 4.6.1. Instrument & accessories market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.7. Services
- 4.7.1. Services market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 5. Telesurgery Market Segment Analysis, By Application, 2021-2033 (USD Million)
- 5.1. Definition and Scope
- 5.2. Application Market Share Analysis, 2025 & 2033
- 5.3. Segment Dashboard
- 5.4. Global Telesurgery Market, by Application, 2021 to 2033
- 5.5. General surgery
- 5.5.1. General surgery market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.6. Urological surgery
- 5.6.1. Urological surgery market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.7. Gynecological surgery
- 5.7.1. Gynecological surgery market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.8. Cardiovascular surgery
- 5.8.1. Cardiovascular surgery market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.9. Others
- 5.9.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 6. Telesurgery Market Segment Analysis, By End Use, 2021-2033 (USD Million)
- 6.1. Definition and Scope
- 6.2. End use Market Share Analysis, 2025 & 2033
- 6.3. Segment Dashboard
- 6.4. Global Telesurgery Market, by End use, 2021 to 2033
- 6.5. Hospitals
- 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.6. Outpatient facilities
- 6.6.1. Outpatient facilities market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.7. Research and academic institutions
- 6.7.1. Research and academic institutions market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 7. Telesurgery Market Segment Analysis, By Region, 2021- 2033 (USD Million)
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. Telesurgery Market Share by Region, 2025 & 2033:
- 7.5. North America
- 7.5.1. North America telesurgery market, 2021 - 2033 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive scenario
- 7.5.2.4. U.S. telesurgery market, 2021 - 2033 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive scenario
- 7.5.3.4. Canada telesurgery market, 2021 - 2033 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Mexico telesurgery market, 2021 - 2033 (USD Million)
- 7.6. Europe
- 7.6.1. Europe telesurgery market, 2021 - 2033 (USD Million)
- 7.6.2. UK
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive scenario
- 7.6.2.4. UK telesurgery market, 2021 - 2033 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework
- 7.6.3.3. Competitive scenario
- 7.6.3.4. Germany telesurgery market, 2021 - 2033 (USD Million)
- 7.6.4. France
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework
- 7.6.4.3. Competitive scenario
- 7.6.4.4. France telesurgery market, 2021 - 2033 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework
- 7.6.5.3. Competitive scenario
- 7.6.5.4. Italy telesurgery market, 2021 - 2033 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Spain telesurgery market, 2021 - 2033 (USD Million)
- 7.6.7. Norway
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Regulatory framework
- 7.6.7.3. Competitive scenario
- 7.6.7.4. Norway telesurgery market, 2021 - 2033 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Regulatory framework
- 7.6.8.3. Competitive scenario
- 7.6.8.4. Sweden telesurgery market, 2021 - 2033 (USD Million)
- 7.6.9. Denmark
- 7.6.9.1. Key country dynamics
- 7.6.9.2. Regulatory framework
- 7.6.9.3. Competitive scenario
- 7.6.9.4. Denmark telesurgery market, 2021 - 2033 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework
- 7.7.1.3. Competitive scenario
- 7.7.1.4. Japan telesurgery market, 2021 - 2033 (USD Million)
- 7.7.2. China
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive scenario
- 7.7.2.4. China telesurgery market, 2021 - 2033 (USD Million)
- 7.7.3. India
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework
- 7.7.3.3. Competitive scenario
- 7.7.3.4. India telesurgery market, 2021 - 2033 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Australia telesurgery market, 2021 - 2033 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Regulatory framework
- 7.7.5.3. Competitive scenario
- 7.7.5.4. South Korea telesurgery market, 2021 - 2033 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Regulatory framework
- 7.7.6.3. Competitive scenario
- 7.7.6.4. Thailand telesurgery market, 2021 - 2033 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Regulatory framework
- 7.8.1.3. Competitive scenario
- 7.8.1.4. Brazil telesurgery market, 2021 - 2033 (USD Million)
- 7.8.2. Argentina
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Argentina telesurgery market, 2021 - 2033 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Regulatory framework
- 7.9.1.3. Competitive scenario
- 7.9.1.4. South Africa telesurgery market, 2021 - 2033 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Regulatory framework
- 7.9.2.3. Competitive scenario
- 7.9.2.4. Saudi Arabia telesurgery market, 2021 - 2033 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Regulatory framework
- 7.9.3.3. Competitive scenario
- 7.9.3.4. UAE telesurgery market, 2021 - 2033 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Regulatory framework
- 7.9.4.3. Competitive scenario
- 7.9.4.4. Kuwait telesurgery market, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Profiles
- 8.3.1. Intuitive Surgical
- 8.3.1.1. Company overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. Sina Robotics & Medical Innovators Co., Ltd
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. Asensus Surgical US, Inc.
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. SS Innovations International Inc.
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. RIVERFIELD Inc.
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Siemens Healthcare
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. MicroPort
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Sovato Health, Inc.
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. LIVSMED, INC
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. CMR Surgical Ltd.
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
